Logo

Juno Diagnostics: Todd Whitson

Oct 06, 2022

Noninvasive prenatal screening firm Juno Diagnostics has appointed Todd Whitson as executive VP of global business development and commercial operations. Whitson previously served as chief commercial and strategy officer at NephroSant, a kidney disease diagnostics company. He was also chief commercial officer at transplant diagnostics firm CareDx and VP of commercial operations at another noninvasive prenatal testing company, Ariosa Diagnostics.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.